[go: up one dir, main page]

GB2466110B - Antibacterial formulation for use in the treatment of acne - Google Patents

Antibacterial formulation for use in the treatment of acne

Info

Publication number
GB2466110B
GB2466110B GB0921378A GB0921378A GB2466110B GB 2466110 B GB2466110 B GB 2466110B GB 0921378 A GB0921378 A GB 0921378A GB 0921378 A GB0921378 A GB 0921378A GB 2466110 B GB2466110 B GB 2466110B
Authority
GB
United Kingdom
Prior art keywords
acne
treatment
antibacterial formulation
antibacterial
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0921378A
Other versions
GB2466110A (en
GB0921378D0 (en
Inventor
Daniel James Fitzgerald
Scott Seville
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntopix Group PLC
Original Assignee
Syntopix Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntopix Group PLC filed Critical Syntopix Group PLC
Publication of GB0921378D0 publication Critical patent/GB0921378D0/en
Publication of GB2466110A publication Critical patent/GB2466110A/en
Application granted granted Critical
Publication of GB2466110B publication Critical patent/GB2466110B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0921378A 2008-12-09 2009-12-07 Antibacterial formulation for use in the treatment of acne Expired - Fee Related GB2466110B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0822394.3A GB0822394D0 (en) 2008-12-09 2008-12-09 Formulations

Publications (3)

Publication Number Publication Date
GB0921378D0 GB0921378D0 (en) 2010-01-20
GB2466110A GB2466110A (en) 2010-06-16
GB2466110B true GB2466110B (en) 2011-01-05

Family

ID=40289694

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0822394.3A Ceased GB0822394D0 (en) 2008-12-09 2008-12-09 Formulations
GB0921378A Expired - Fee Related GB2466110B (en) 2008-12-09 2009-12-07 Antibacterial formulation for use in the treatment of acne

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0822394.3A Ceased GB0822394D0 (en) 2008-12-09 2008-12-09 Formulations

Country Status (1)

Country Link
GB (2) GB0822394D0 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015184347A1 (en) * 2014-05-29 2015-12-03 Metabeauty, Inc. Methods and compositions for the use of silver to prevent and treat acne

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB995492A (en) * 1961-03-20 1965-06-16 Johnson & Johnson Antimicrobial compositions containing dequalinium salts
RO59301A2 (en) * 1972-07-26 1976-01-15
JP2000212090A (en) * 1999-01-18 2000-08-02 Mitsuko Ito Skin-modifying agent
US20080070875A1 (en) * 2006-09-11 2008-03-20 Majewski George P Acne treatment compositions and methods of use
WO2008035078A1 (en) * 2006-09-22 2008-03-27 Syntopix Limited Antimicrobial formulations
JP2008110999A (en) * 2008-02-04 2008-05-15 Mandom Corp Antibacterial composition and deodorant agent
GB2450225A (en) * 2007-06-07 2008-12-17 Syntopix Ltd Antimicrobial formulation
GB2456376A (en) * 2008-12-22 2009-07-15 Syntopix Ltd Antibacterial/anti-acne formulations comprising a halogenated salicylanilide in combination with one or more anti-acne agents

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB995492A (en) * 1961-03-20 1965-06-16 Johnson & Johnson Antimicrobial compositions containing dequalinium salts
RO59301A2 (en) * 1972-07-26 1976-01-15
JP2000212090A (en) * 1999-01-18 2000-08-02 Mitsuko Ito Skin-modifying agent
US20080070875A1 (en) * 2006-09-11 2008-03-20 Majewski George P Acne treatment compositions and methods of use
WO2008035078A1 (en) * 2006-09-22 2008-03-27 Syntopix Limited Antimicrobial formulations
GB2450225A (en) * 2007-06-07 2008-12-17 Syntopix Ltd Antimicrobial formulation
JP2008110999A (en) * 2008-02-04 2008-05-15 Mandom Corp Antibacterial composition and deodorant agent
GB2456376A (en) * 2008-12-22 2009-07-15 Syntopix Ltd Antibacterial/anti-acne formulations comprising a halogenated salicylanilide in combination with one or more anti-acne agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015184347A1 (en) * 2014-05-29 2015-12-03 Metabeauty, Inc. Methods and compositions for the use of silver to prevent and treat acne

Also Published As

Publication number Publication date
GB2466110A (en) 2010-06-16
GB0921378D0 (en) 2010-01-20
GB0822394D0 (en) 2009-01-14

Similar Documents

Publication Publication Date Title
IL249941A0 (en) Spiro-oxindole compounds and their use as therapeutic agents
GB2463797B (en) Skin treating device
GB0803018D0 (en) Therapeutic compounds and their use
GB0804685D0 (en) Therapeutic compounds and their use
GB0807609D0 (en) Therapeutic compounds and their use
GB0817208D0 (en) Therapeutic apsap compounds and their use
GB0800145D0 (en) Skincare treatment
HK1160471A1 (en) Aminophosphinic derivatives that can be used in the treatment of pain
GB0808723D0 (en) Cosmetic formulation
IL207965A (en) Compounds for use in the treatment or prophylaxis of pain
GB0822486D0 (en) Compounds for use in the treatment of pain
HRP20151393T8 (en) USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES
GB0812913D0 (en) Therapeutic compounds and their use
GB2466110B (en) Antibacterial formulation for use in the treatment of acne
GB0802128D0 (en) Therapeutic compounds and their use
PL2229943T3 (en) Compounds for use in the treatment of peripheral neuropathy
GB0815134D0 (en) Therapeutic compounds and their use
GB0819037D0 (en) Skin treatment formulation
AU2008905239A0 (en) Skin Treatment Formulation
GB2473735B (en) Skin treatment formulation
AU2009904943A0 (en) Skin Treatment Formulation
AU2007905499A0 (en) Skin Treatment Formulation
AU2007903672A0 (en) Hair treatment formulation
GB0821539D0 (en) Therapeutic compounds and their use
GB0819103D0 (en) Raphaine compounds and their use in therapy

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20131207